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Background: Aquaporin 5 (AQP5), a member of the aquaporin family of transmembrane channel proteins, is involved
in water transport and cellular proliferation in various tumors. The objective of this study was to determine cellular
localization of aquaporin 5 (AQP5) in the ovarian tumors of chicken, a preclinical model for human ovarian tumor and
to determine if AQP5 mRNA and protein expression levels in cancerous chicken ovaries and in ascites-derived chicken
ovarian cancer (COVCAR) cell lines are different from normal ovaries and normal ovarian surface epithelial (NOSE) cells,
respectively.
Methods: Immunohistochemical staining was performed to determine the localization of AQP5-immunoreactive (ir)
cells in normal and cancerous ovaries. To determine AQP5 mRNA and protein concentrations in cancerous ovaries and
COVCAR cell lines, quantitative real time PCR and Western blotting analysis were performed, respectively. Student’s
t-test was performed to compare the levels of AQP5 mRNA or protein in cancerous ovaries and COVCAR cell lines with
that of normal ovaries and NOSE cells, respectively.
Results: AQP5-ir cells were localized in granulosa and theca layers of normal ovarian follicles whereas cancerous
ovaries showed AQP5 immunostaining in the surface epithelium, fibroblast cells of the stroma, and in the cells lining
tumor cysts and acini. AQP5 mRNA concentration were significantly lesser while AQP5 protein concentrations were
significantly greater in cancerous ovaries compared to that in normal ovaries (P < 0.05). Whereas AQP5 mRNA
concentrations were significantly greater while AQP5 protein concentrations were lesser (P < 0.05) in COVCAR cell lines
compared with that in NOSE cells.
Conclusion: AQP5 is differentially expressed in ovarian tumor and in COVCAR cell lines suggesting a potential
involvement of AQP5 in ovarian tumorigenesis, metastasis, and survival of ovarian tumor cells in ascites.
Keywords: Water channel transmembrane protein, Malignancy, Metastasis, Invasiveness, Epithelial ovarian tumorIntroduction
Ovarian cancer is a very complex and heterogeneous dis-
ease that ranks fifth in cancer-related deaths among
women [1,2]. High mortality due to ovarian cancer is at-
tributed to diagnosis of the disease at advanced stages
and high recurrence following first line of treatment.
Advanced stages of ovarian cancers are usually asso-
ciated with ascites formation [3]. Ascites is accumulation
of fluid in the peritoneal cavity as a result of a combi-
nation of several factors including peritoneal lymphatic* Correspondence: RameshR@psu.edu
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unless otherwise stated.obstruction by tumor cells causing impaired lymphatic
drainage [4], rupture of organ/tissue architecture leading
to plasma leak into the peritoneal cavity [5], and secre-
tion of vascular permeability factors by tumor cells [6].
Furthermore, imbalances in water transport could result
from alterations in expression of water channel proteins
such as aquaporin (AQP).
The aquaporins are a family of integral membrane
proteins that facilitate water transport across the cell
membrane [7]. In addition to water transport, aquapo-
rins are reported to play a major role in angiogenesis,
cell migration [8], cell proliferation [9], cell volumetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Tiwari et al. Journal of Ovarian Research 2014, 7:99 Page 2 of 8
http://www.ovarianresearch.com/content/7/1/99regulation, mitochondrial metabolism, and apoptosis
[10]. Expression of aquaporins was found to be altered
in tumors of various organs such as brain [11], colon
[12], breast, prostate, lung, and ovary. AQP1, AQP5 and
AQP9 expression was found to be higher in malignant
and borderline ovarian tumors compared to benign
ovarian tumor and normal ovaries [13]. AQP1 was pre-
dominantly expressed in microvascular endothelium of
the ovary tissue but found rarely in ovarian tumor cells
[13,14]. AQP9, an aquaglyceroporin responsible for gly-
cerol and water transport expressed in normal ovarian
surface epithelium, was found to be overexpressed in
borderline and malignant tumors [13]. Similar to AQP9,
AQP5 expression was reported to be higher in ovarian
tumors associated with lymph node metastasis [13].
Laying hens are emerging to be the most appropriate
animal model for human ovarian cancer as they develop
ovarian tumor spontaneously similar to women with a
very high rate of incidence as high as 50% during 2–4
years of age [15-17]. Laying hens mimic human ovarian
tumor, exhibiting similar disease progression and histo-
logical features [18]. Advanced stages of ovarian tumors
in chickens as in human are typically associated with the
presence of ascites. Recently, we have characterized va-
rious ovarian tumor cell lines obtained from ascites of
laying hens that had advanced stages of ovarian tumors
[19]. Large volumes of ascites, as high as 800 ml or
approximately 70% of body weight, accumulate in the
viscera of chickens at advanced stages of ovarian tumor
[19]. Since greater AQP5 expression has been positively
correlated with ascites volume and lymph node me-
tastasis in human subjects with ovarian tumor [13], we
sought to elucidate the expression of AQP5 in the
chicken model of ovarian tumor and in ascites-derived
chicken ovarian cancer (COVCAR) cell lines. We hy-
pothesized that AQP5 expression is altered in COVCAR
cells and in cancerous ovaries obtained from highly
metastatic ovarian tumors compared to normal ovarian
surface epithelial (NOSE) cells and normal ovaries, re-
spectively. The objective of this study was to determine
cellular localization of AQP5 in normal and cancerous
chicken ovaries and to determine if AQP5 mRNA and
protein quantities are different in chicken ovarian tu-
mors and in COVCAR cells compared to that in normal
ovaries and NOSE cells, respectively.
Materials and methods
Animals
Single-comb White Leghorn chickens were provided un-
restricted access to feed and water at all times and main-
tained at 16 h light and 8 h dark cycle. All animal
procedures were carried out in accordance with the
Institutional Animal Care and Use Committee approved
protocol.Tissue collection and cell culture
Normal and cancerous ovaries were collected from
chickens (3–4 years-old; n = 5) as described previously
[19]. After collection, normal and tumorous ovaries were
either frozen in liquid nitrogen and stored at −80°C for
extraction of protein and RNA or fixed in Bouin’s fixa-
tive solution for histopathology. Ovary tissue fixed in
Bouin’s fixative solution was dehydrated and embedded
in paraffin to prepare 4–6 μm thick tissue sections for
histology and immunohistochemistry. Ascites was col-
lected aseptically for isolation and culture of ovarian
cancer (COVCAR) cells, as described previously [19].
COVCAR cells lines (C5, C6, C7, C11, and C19) were
cultured in MCDB105-M199 cell culture medium at
37°C and 5% CO2. Upon reaching 80-90% confluence,
the cells were passaged and replated at 1:1 or 1:2 ratio.
Total RNA and protein were extracted from COVCAR
cells (passages 3–4) as described previously [19]. To
serve as control for COVCAR cells, normal ovarian
surface epithelial (NOSE) cells were obtained by gentle
scraping of the surface of pre-ovulatory follicles col-
lected from regularly ovulating healthy chickens. The
NOSE cells were cultured under identical conditions as
used for COVCAR cell culture until they reached 80-
90% confluence before preparation of cellular lysates for
protein and RNA extraction. We have previously cha-
racterized the COVCAR cells lines (C5, C6, C7, C11,
and C19) as to their invasiveness in extracellular matrix,
ability to grow in soft agar and elevated expression of
several ovarian tumor associated genes or proteins in-
cluding E-cadherin [19].
Histopathology and immunohistochemistry
Normal and cancerous ovary tissue sections (n = 5 animals)
were deparaffinized in Histoclear (Electron Microscopy
Sciences, Hatfield, PA) and hydrated using descending
concentrations of ethyl alcohol in water. Tissue sections
were stained with hematoxylin and eosin for histopatho-
logical examination by a board-certified veterinary patho-
logist (Dr. Timothy Cooper, Hershey Medical Center,
Pennsylvania State University). For immunohistochemical
staining, an antigen retrieval procedure was performed by
boiling tissue sections in 10 mM sodium citrate solution
(pH 6.0) in a pressure cooker. Endogenous peroxidase ac-
tivity was quenched using 3% H2O2 in methanol. After
several washes in Tris-buffered saline (TBS) containing
0.5% Triton X-100 (TBSX; Sigma-Aldrich), tissue sections
were incubated in 1% normal horse serum in TBSX at
ambient room temperature followed by overnight incuba-
tion in goat anti-human AQP5 antibody (2 μg/ml; cat #
SC-9891, Santa Cruz Biotechnology, Santa Cruz, CA).
The immunogen used for producing anti-human AQP5
antibody is 89% homologous to the respective chicken
AQP5 protein sequence. After several washes, tissue
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ary antibody (6 μg/ml, Vector Laboratories, Burlingame,
CA) in TBSX. Tissue sections were then incubated in
avidin-peroxidase supplied in Vectastain ABC elite kit
(Vector Laboratories) followed by treatment with 3,3’-
diaminobenzidine substrate solution (Vector Laboratories).
After dehydration of tissue sections, the slides were visua-
lized and photographed in an Axioskop microscope (Zeiss,
New York, NY). For negative control, ovary tissue sections
were incubated in 1% normal horse serum (Vector La-
boratories) in TBSX for 1 h at ambient room temperature
followed by overnight incubation in 1% normal horse
serum (Vector Laboratories) in TBSX in place of goat
anti-human AQP5 antibody.
Real-time quantitative PCR
Total RNA was extracted from ovary tissue (cancerous
and normal, n = 5) and cell lines (COVCAR and NOSE
cells, n = 5) and reverse transcribed as described previ-
ously [19]. Briefly, 50 ng of cDNA prepared from total
RNA extracted from each ovary tissue and cell line was
mixed with 1X PerfeCTa SYBR Green Fastmix (Quanta
Biosciences, Gaithersburg, MD), and 300 nM forward and
reverse primers to amplify chicken AQP5 cDNA (Fwd:
GCTCTGCTGTACTTCTACATCCTTGT, Rev: ATTT
CTTCCTCTCCTCTCTCTGTTCT) or chicken β-actin
(Fwd: CTGGCACCTAGCACAATGAA; Rev: CTGCTTG
CTGATCCACATCT). Reactions were carried out in 7500
Fast-Real Time PCR System (Life Technologies) with the
following thermal cycle: 95°C for 20 sec followed by 35 cy-
cles of 95°C for 3 sec, 55°C for 10 sec and 63°C for 30 sec.
At the end of amplification, a melting curve analysis was
performed to confirm the presence of a single amplifica-
tion product. Samples from each ovary tissue and cell line
were run in triplicate to obtain average CT values for
AQP5 mRNA and β-actin mRNA. The log-linear thresh-
old values (CT) during the exponential phase of the PCR
for target mRNA were normalized to β-actin mRNA.
AQP5 mRNA quantity was expressed as a proportion to
β-actin quantity following 2 –ΔΔCT method for converting
log-linear CT values to linear term [20] and analyzed.
Western blotting analysis
Protein lysates of ovary tissue (cancerous and normal,
n = 5) and cell lines (COVCAR and NOSE cells, n = 5)
were prepared as described previously [19]. The lysates
were denatured, heated for 10 min at 95°C, and separated
on a 10% Bis-Tris polyacrylamide gel (Invitrogen) in
3-(N-morpholino)propanesulfonic acid (MOPS) running
buffer. Proteins were transferred to Immun-Blot polyviny-
lidene difluoride (PVDF) membrane and first incubated in
5% non-fat dry milk and then with affinity-purified goat
anti-human AQP5 antibody (0.4 μg/ml; Santa Cruz
Biotechnology). After several washes, membranes wereincubated in horseradish peroxidase labeled donkey anti-
goat IgG (0.08 μg/ml; Santa Cruz Biotechnology) and
treated with WesternSure PREMIUM Chemiluminescent
Substrate (LI-COR Biosciences, Lincoln, NE). Chemilu-
minescent signals were detected using the C-Digit blot
scanner (LI-COR Biosciences) and analyzed using Image
Studio Lite software version 3.1 (LI-COR Biosciences).
Membranes were reprobed with mouse anti-chicken
α-tubulin antibody (0.25 μg/ml; Sigma-Aldrich) followed
by incubation in horseradish peroxidase labeled goat anti-
mouse IgG (0.08 μg/ml; Pierce) and scanned as described
above. AQP5 protein quantity was expressed as a propor-
tion of α-tubulin levels and compared between cancerous
and normal ovaries or between COVCAR cell lines and
NOSE cells. To determine the specificity of AQP5 immu-
nostaining, the primary antibody was preadsorbed with
2 μg/ml of AQP5 blocking peptide (cat # SC-9891, Santa
Cruz Biotechnology) and used in Western blot analysis.
Statistical analyses
All data were analyzed using SigmaPlot version 12
(Systat Software Inc, San Jose, CA, USA). Levels of AQP5
mRNA or protein in cancerous ovaries and COVCAR cell
lines were compared with that of normal ovaries and
NOSE cell lines, respectively, using student’s t-test. A
probability level of P < 0.05 was considered as statistically
significant.
Results
Ovarian tumor gross morphology and histopathology
Representative photographs of normal ovary (Figure 1A)
reveal a typical hierarchy of five preovulatory follicles and
post-ovulatory follicular membrane whereas the cancerous
ovary (Figure 1B) contained numerous prehierarchical fol-
licles and cauliflower-like tumor mass. Photomicrographs
of the normal ovarian stroma (Figure 1C and E) contained
cross-sections of several ovarian follicles that have typi-
cal arrangement of theca and/or granulosa cell layers
surrounding oocyte. In cancerous ovaries, the tissue was
found to be expanded and nearly completely effaced by
a large, invasive, unencapsulated, multinodular mass
consisting of poorly differentiated epithelial cells ar-
ranged in tubules and acini separated by abundant stroma
(Figure 1D). Epithelial cells appeared cuboidal with scant
to moderate vacuolated eosinophilic to faintly basophilic
cytoplasm and large round central nuclei (Figure 1F).
Localization of AQP5 immunoreactive cells in normal and
cancerous ovaries
AQP5 immunoreactive (ir) cells were found predomi-
nantly in the granulosa and theca externa layers in normal
ovarian prehierarchical follicles (Figure 2A and B). The
pattern of AQP5 immunostaining appeared different in














NORMAL OVARY CANCEROUS OVARY
Figure 1 Gross morphology and histology of normal and cancerous ovaries of chicken. A. Normal ovary containing a hierarchy of
preovulatory follicles (F1-F5), pre- hierarchical follicles (SYF), and post-ovulatory follicles (POF); B. Cancerous ovary containing tumor mass (arrow)
in addition to a few atretic preovulatory follicles; C-F. Photomicrographs of normal (C, E) and cancerous (D, F) ovarian tissue sections stained with
hematoxylin and eosin. SYF-small yellow follicle, POF-post-ovulatory follicle.
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contrast to a thin layer of AQP5-ir cells in the normal OSE
(Figure 2C). Flattened cells lining the cystic spaces in
ovarian tumor were found to be strongly immuno-
reactive to AQP5 (Figure 2E, 2 F). Several acini-like
structures uniformly contained AQP5-ir cells (Figure 2G
and H). Some of the prehierarchial follicles in cancerous
ovaries displayed strong AQP5 immunoreactivity in the
theca cell layer (Figure 2I) while others showed dis-
tended theca cell layer containing several AQP5-ir cells
(Figure 2J). AQP5-ir cells were also found in flattened
cells surrounding tumor nodules (Figure 2K). Omission of
anti-AQP5 antibody completely abolished immunostaining
(Figure 2L) confirming the specificity of anti-human AQP5
antibody in detecting chicken AQP5.AQP5 mRNA and protein expressions in cancerous ovaries
AQP5 protein in cancerous and normal ovaries ap-
peared as 39 kDa band (Figure 3). Pre-adsorption of
anti-human AQP5 antibody with human AQP5 peptide
completely abolished the AQP5 immunostaining in
ovarian lysate (Figure 3). AQP5 mRNA levels were sig-
nificantly lesser in cancerous ovaries compared to that
in normal ovaries (n = 5; Figure 4A). Interestingly,
AQP5 protein levels were approximately 2-fold greater
in cancerous ovaries compared to that in normal ovaries
(Figure 4B).
AQP5 mRNA and protein expressions in COVCAR cell lines
AQP5 mRNA concentration was found to be approxi-


























Figure 2 Representative photomicrographs of normal and cancerous ovarian tissue sections showing AQP5-immunostained cells.
Bouin’s solution-fixed ovary tissue sections were immunostained using anti-human AQP5 antibody. AQP5 immunostaining (brown color) was visualized
using a peroxidase-based detection system. A-C. Normal ovarian tissue sections exhibiting localization of AQP5 in granulosa and theca cell layers
(arrows in A and B) and in ovarian surface epithelium (C); D-L. Cancerous ovarian tissue sections exhibiting localization of AQP5 in ovarian surface
epithelium (arrow in D), borders around cysts (E, F), acini (arrow in G and H), theca cell layer (arrow in I), and in lobules of poorly differentiated neoplastic
cells (arrows in J and K). Omitting anti-AQP5 antibody during the staining procedure abolished immunostaining completely (L). GCL- granulosa cell layer,
TCL-theca cell layer, OSE-ovarian surface epithelium, CS-cystic space, Ac-acinus.
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COVCAR cell lysates appeared as 39 kDa band, similar to
one observed in cancerous or normal ovaries (Figure 4).
In addition, unlike ovary tissue lysate, COVCAR cell ly-
sates exhibited three other bands of masses approximately
48, 51, and 60 kDa (Figure 3) that are possibly variants of
AQP5 or non-specific immunostaining as pre-adsorption
of anti-AQP5 antibody with AQP5 peptide completely
abolished the 39 and 60 kDa AQP5 bands but not the 48
or 51 kDa bands (Figure 4). Upon quantification, the
39 kDa AQP5 protein levels in COVCAR cells were sig-
nificantly lesser than that in NOSE cells (Figure 5B).
Discussion
This is the first report to describe AQP5 expression in
the chicken ovarian tumor model. In the normal ovaryof chicken, AQP5 expression was found to be localized
in the OSE, granulosa and theca cells. Similar to chick-
ens, normal pig ovaries express AQP5 in granulosa and
flattened follicular cells of primordial follicles [21]. The
role of AQP5 in granulosa or thecal cell function and
the factors affecting AQP5 expression remain to be
elucidated. Based on the cell types where AQP5 is
expressed in the ovary, it is plausible that AQP5 is in-
volved in water transport in the developing follicle, yolk
deposition, and in steroidogenesis. Coincidentally, pro-
gesterone treatment alone or in combination with estro-
gen was found to increase in AQP5 expression in rat
uterine tissues demonstrated by situ hybridization histo-
chemistry [22]. Using a similar approach, an increase in
expression of AQP5 was reported in the glandular epi-
thelium of progesterone-primed uteri following estrogen
Blocking Peptide+Blocking Peptide-
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Figure 3 Western blot analyses to detect AQP5 in cancerous
ovaries and ascites-derived chicken ovarian cancer (COVCAR)
cells. Protein extracts from ovary tissue and COVCAR cells were
subjected to Western blot analysis under reducing conditions. AQP5
protein was detected by immunostaining using anti-human AQP5
antibody (−Blocking Peptide) and chemiluminescence. Specificity of
AQP5 antibody was determined by preadsorption of anti-human
AQP5 antibody with human AQP5 peptide (+Blocking peptide).





























































Figure 4 Quantification of AQP5 mRNA and AQP5 protein in
cancerous ovaries. A. Quantification of AQP5 mRNA in cancerous
ovaries. Total RNA extracted from cancerous and normal ovaries (n = 5
animals), was DNAse-I digested and reverse transcribed. Following
reverse transcription, approximately 50 ng of cDNA was used in
quantitative real-time PCR using SYBR® green as the dye to quantify
AQP5 mRNA and β-actin mRNA in separate reactions. Each reaction
was run in triplicate per tissue sample; and the critical threshold (CT)
values, averaged, normalized to that of β-actin mRNA and converted
from log-linear to linear term; B. Quantification of AQP5 protein in
cancerous and normal ovaries. Protein extracts from cancerous ovaries
(n = 5 animals) were subjected to Western blot analysis under reducing
conditions. Chicken AQP5 protein was detected by immunostaining
using anti-human AQP5 antibody and chemiluminescence.
Alpha-tubulin was used as loading control. Data are represented
as mean ± standard error of the mean from 5 replicates. *P < 0.05;
cancerous versus normal ovary.
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AQP5 expression appears to be regulated by gonadal
steroids in female reproductive tract.
We found that cancerous ovaries of the chicken exhi-
bited several layers of AQP5-ir cells extending from the
ovarian surface inwards. A board-certified histopatholo-
gist has determined the histotype of the cancerous ova-
ries used in this study as endometrioid type of ovarian
adenocarcinoma [19]. In addition to the surface epithe-
lium, AQP5 was expressed in the ovarian stroma, acini
and in the cell lining the cysts. Presence of AQP5 in cells
lining the cysts may suggest a potential role of AQP5 in
formation of cystic fluid and secretions possibly required
for the survival and growth of cancer cells. Similar to
the chicken ovarian tumor, AQP5 localization has also
been demonstrated in human ovarian tumor with
localization of AQP5 protein in basolateral membrane of
epithelial layer in benign tumor and plasma membranes
of borderline and malignant tumors [13]. However, fac-
tors affecting AQP5 expression in cancerous ovaries are
yet to be understood.
Our data suggest that AQP5 mRNA concentrations
were 3-fold lesser in cancerous ovaries compared to that
in normal ovaries. In contrast to our findings, AQP5
mRNA expression levels were found to be elevated inmalignant ovarian tumors in women and such an in-
crease was positively correlated to the ascites volume
[24]. Such discordance may be due to species variation
and may possibly indicate that regulation of AQP5 gene
transcription and AQP5 mRNA turnover is different in
chickens compared to humans. Although AQP5 mRNA
concentrations were significantly lesser in cancerous
ovaries in the chicken model, AQP5 protein concentra-
tions were found to be significantly greater in the can-
cerous ovaries compared to that in normal ovaries. The
negative correlation between AQP5 mRNA and protein
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Figure 5 Quantification of AQP5 mRNA and AQP5 protein in
ascites-derived chicken ovarian cancer (COVCAR) cells.
A. Quantification of AQP5 mRNA in COVCAR cells. Total RNA
extracted from COVCAR cells (n = 5 cell lines; C5, C6, C7, C11, and
C19) and normal ovarian surface epithelial cell lines (NOSE; n = 5 cell
lines), was DNAse-I digested and reverse transcribed. Following
reverse transcription, approximately 50 ng of cDNA was used in
quantitative real-time PCR using SYBR® green as the dye to quantify
AQP5 mRNA and β-actin mRNA in separate reactions. Each reaction
was run in triplicate per cell line; and the critical threshold (CT)
values, averaged, normalized to that of β-actin mRNA and converted
from log-linear to linear term; B. Quantification of AQP5 protein in
COVCAR cells. Protein extracts from COVCAR cells (n = 5 cell lines;
C5, C6, C7, C11 and C19), and NOSE cells (n = 5 cell lines) were
subjected to Western blot analysis under reducing conditions.
Chicken AQP5 protein was detected by immunostaining using
anti-human AQP5 antibody and chemiluminescence. Alpha-tubulin
was used as loading control. Data are represented as mean ± standard
error of the mean from 5 replicates. *P < 0.05; **P < 0.001 COVCAR
versus NOSE cells.
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modification, mRNA stability and processing. Consistent
with our findings, higher AQP5 protein expression has
been reported in borderline and malignant cancerous
ovaries in women [13]. Data originating from several
in vitro studies suggests that AQP5 is associated with
increased proliferation, migration and decreased apoptosis
in various tumor cell lines. For instance, lentivirus-
mediated AQP5-shRNA transduction or hyperosmotic
stress induced by sorbitol in MCF7 breast cancer cell linelead to attenuation of cell proliferation and migration
[25,26]. Overexpression of AQP5 enhanced whereas, in-
hibition of AQP5 by acetazolamide significantly attenuated
the proliferation and migration of gastric carcinoma cells
[26]. Similarly, overexpression of AQP5 resulted in in-
creased cell proliferation whereas small interfering RNA
(siRNA) against AQP5 reduced cell proliferation rate in
K562 and LAMA84 chronic myeloid leukemia cells [27].
Tumor necrosis factor-α, a pro-inflammatory cytokine
that is elevated in tumors of various organs including
ovaries [28] and breast [29], has been found to decrease
AQP5 expression in acinar cells of human salivary gland
via histone H4 acetylation [30]. However, treatment of
CAOV3 ovarian cancer cell line with cisplatin decreases
AQP5 protein expression and growth rate [31]. Similarly,
epigallocatechin gallate treatment decreases AQP5 mRNA
concentrations causing a decrease in proliferation of
SKOV3 ovarian cancer cells [32]. Based on the foregoing,
it is imperative to understand the direct role of AQP5 in
ovarian tumor cell physiology.
We have previously reported that the ascites-derived
COVCAR cell lines used in the present study are highly
proliferative and possess greater invasiveness in Matrigel
extracellular matrix compared to that of NOSE cells [19].
Considering the potential role of AQP5 in tumor cell pro-
liferation and migration, we examined the AQP5 mRNA
and protein expression levels in the COVCAR cell lines.
Our data suggest that AQP5 mRNA in COVCAR cell
lines were 2.5-fold greater than that in NOSE cells. Epi-
genetic changes such as CpG methylation in the promoter
region of the AQP5 gene affects AQP5 mRNA expression
in such a way that hypermethylation leads to repression of
the gene expression and hypomethylation leads to in-
creased gene expression [33]. Greater AQP5 mRNA in
COVCAR cells in our studies may be due to hypomethyla-
tion of AQP5 gene. AQP5 protein levels, however, were
found to be significantly lower in COVCAR cells com-
pared to that in NOSE cells. Discordant mRNA and
protein levels are not uncommon and could be attributed
to several factors such as increased turnover of AQP5
protein leading to feedback upregulation of AQP5 gene
expression. It is intriguing that AQP5 protein concentra-
tions are downregulated in the COVCAR cell lines but up-
regulated in the cancerous ovaries. COVCAR cells are
derived from ascites and as such these floating metastatic
cells may have adapted to thrive in ascites by downregu-
lating AQP5 protein levels and restricting water transport
across the cell membrane. However, the tumor cells
within the ovary would still require a higher level of AQP5
for proliferation and migration. It is not clear what factors
are responsible to decrease AQP5 protein levels in the
COVCAR cell lines.
In summary, our data have revealed a differential dis-
tribution of AQP5-ir cells in the ovarian tumor tissue
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role of AQP5 in proliferation and invasiveness of ovarian
tumor cells. Similarly, AQP5 mRNA or protein concen-
trations in cancerous ovaries and COVCAR cells were
found to be different from normal ovaries and NOSE
cells, respectively. Collectively, our data suggest that
altered expression of AQP5 may influence ovarian tumor
cell proliferation, migration, and survival in ascites.
Future studies should focus on exploring the pathways
involved in altered AQP5 expression and its potential
role in tumorigenesis in the chicken model of ovarian
tumor.
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